These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 30594032)

  • 1. Toward steroidal anticancer drugs: Non-parametric and 3D-QSAR modeling of 17-picolyl and 17-picolinylidene androstanes with antiproliferative activity on breast adenocarcinoma cells.
    Kovačević SZ; Karadžić MŽ; Vukić DV; Vukić VR; Podunavac-Kuzmanović SO; Jevrić LR; Ajduković JJ
    J Mol Graph Model; 2019 Mar; 87():240-249. PubMed ID: 30594032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive QSRR modeling as a starting point in characterization and further development of anticancer drugs based on 17α-picolyl and 17(E)-picolinylidene androstane structures.
    Kovačević SZ; Podunavac-Kuzmanović SO; Jevrić LR; Jovanov PT; Djurendić EA; Ajduković JJ
    Eur J Pharm Sci; 2016 Oct; 93():1-10. PubMed ID: 27418311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 17(E)-picolinylidene androstane derivatives as potential inhibitors of prostate cancer cell growth: antiproliferative activity and molecular docking studies.
    Ajduković JJ; Djurendić EA; Petri ET; Klisurić OR; Celić AS; Sakač MN; Jakimov DS; Gaši KM
    Bioorg Med Chem; 2013 Dec; 21(23):7257-66. PubMed ID: 24148837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preselection of A- and B- modified d-homo lactone and d-seco androstane derivatives as potent compounds with antiproliferative activity against breast and prostate cancer cells - QSAR approach and molecular docking analysis.
    Kovačević SZ; Podunavac-Kuzmanović SO; Jevrić LR; Vukić VR; Savić MP; Djurendić EA
    Eur J Pharm Sci; 2016 Oct; 93():107-13. PubMed ID: 27503457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, structural analysis and antitumor activity of novel 17α-picolyl and 17(E)-picolinylidene A-modified androstane derivatives.
    Ajduković JJ; Penov Gaši KM; Jakimov DS; Klisurić OR; Jovanović-Šanta SS; Sakač MN; Aleksić LD; Djurendić EA
    Bioorg Med Chem; 2015 Apr; 23(7):1557-68. PubMed ID: 25737400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androstane derivatives induce apoptotic death in MDA-MB-231 breast cancer cells.
    Jakimov DS; Kojić VV; Aleksić LD; Bogdanović GM; Ajduković JJ; Djurendić EA; Penov Gaši KM; Sakač MN; Jovanović-Šanta SS
    Bioorg Med Chem; 2015 Nov; 23(22):7189-98. PubMed ID: 26494582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-linear assessment of anticancer activity of 17-picolyl and 17-picolinylidene androstane derivatives--chemometric guidelines for further syntheses.
    Kovačević SZ; Podunavac-Kuzmanović SO; Jevrić LR; Djurendić EA; Ajduković JJ
    Eur J Pharm Sci; 2014 Oct; 62():258-66. PubMed ID: 24929053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3D QSAR studies, pharmacophore modeling and virtual screening on a series of steroidal aromatase inhibitors.
    Xie H; Qiu K; Xie X
    Int J Mol Sci; 2014 Nov; 15(11):20927-47. PubMed ID: 25405729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and cytotoxic activity of some 17-picolyl and 17-picolinylidene androstane derivatives.
    Djurendić EA; Ajduković JJ; Sakač MN; Csanádi JJ; Kojić VV; Bogdanović GM; Penov Gaši KM
    Eur J Med Chem; 2012 Aug; 54():784-92. PubMed ID: 22770744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer.
    Nagar S; Saha A
    J Comput Chem; 2010 Sep; 31(12):2342-53. PubMed ID: 20340106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, antitumor evaluation and 3D-QSAR studies of [1,2,4]triazolo[4,3-b][1,2,4,5]tetrazine derivatives.
    Xu F; Yang ZZ; Ke ZL; Xi LM; Yan QD; Yang WQ; Zhu LQ; Lin FL; Lv WK; Wu HG; Wang J; Li HB
    Bioorg Med Chem Lett; 2016 Oct; 26(19):4580-4586. PubMed ID: 27597251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tumor efficacy of new 7α-substituted androstanes as aromatase inhibitors in hormone-sensitive and resistant breast cancer cells.
    Amaral C; Varela CL; Maurício J; Sobral AF; Costa SC; Roleira FMF; Tavares-da-Silva EJ; Correia-da-Silva G; Teixeira N
    J Steroid Biochem Mol Biol; 2017 Jul; 171():218-228. PubMed ID: 28396197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization, pharmacophore modeling and 3D-QSAR studies of sipholanes as breast cancer migration and proliferation inhibitors.
    Foudah AI; Sallam AA; Akl MR; El Sayed KA
    Eur J Med Chem; 2014 Feb; 73():310-24. PubMed ID: 24487236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative validated molecular modeling of p53-HDM2 inhibitors as antiproliferative agents.
    Mondal C; Halder AK; Adhikari N; Saha A; Saha KD; Gayen S; Jha T
    Eur J Med Chem; 2015 Jan; 90():860-75. PubMed ID: 25535952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the Structural Features of Guanine Derivatives as MGMT Inhibitors Using 3D-QSAR Modeling Combined with Molecular Docking.
    Sun G; Fan T; Zhang N; Ren T; Zhao L; Zhong R
    Molecules; 2016 Jun; 21(7):. PubMed ID: 27347909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico ADMET analysis of the A-, B- and D-modified androstane derivatives with potential anticancer effects.
    Šestić TL; Ajduković JJ; Marinović MA; Petri ET; Savić MP
    Steroids; 2023 Jan; 189():109147. PubMed ID: 36410412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.
    Bhongade BA; Gadad AK
    J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D-QSAR studies of heterocyclic quinones with inhibitory activity on vascular smooth muscle cell proliferation using pharmacophore-based alignment.
    Ryu CK; Lee Y; Park SG; You HJ; Lee RY; Lee SY; Choi S
    Bioorg Med Chem; 2008 Nov; 16(22):9772-9. PubMed ID: 18930405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D QSAR pharmacophore, CoMFA and CoMSIA based design and docking studies on phenyl alkyl ketones as inhibitors of phosphodiesterase 4.
    Gaurav A; Singh R
    Med Chem; 2012 Sep; 8(5):894-912. PubMed ID: 22741782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, pharmacological evaluation and in silico ADMET prediction of novel substituted benzimidazole derivatives as angiotensin II-AT1 receptor antagonists based on predictive 3D QSAR models.
    Vyas VK; Gupta N; Ghate M; Patel S
    SAR QSAR Environ Res; 2014; 25(2):117-46. PubMed ID: 24598006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.